| Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. | |
| | |
MedLine Citation:
|
PMID: 20739445 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), (n-3) fatty acids from fish oil, have immune-modulating effects and may improve nutritional status in cancer. The objective of this study was to investigate the effects of an oral nutritional supplement containing (n-3) fatty acids on nutritional status and inflammatory markers in patients with non-small cell lung cancer (NSCLC) undergoing multimodality treatment. In a double-blind experiment, 40 patients with stage III NSCLC were randomly assigned to receive 2 cans/d of a protein- and energy-dense oral nutritional supplement containing (n-3) fatty acids (2.0 g EPA + 0.9 g DHA/d) or an isocaloric control supplement. EPA in plasma phospholipids, energy intake, resting energy expenditure (REE), body weight, fat free mass (FFM), mid-upper arm circumference (MUAC), and inflammatory markers were assessed. Effects of intervention were analyzed by generalized estimating equations and expressed as regression coefficients (B). The intervention group (I) had a better weight maintenance than the control (C) group after 2 and 4 wk (B = 1.3 and 1.7 kg, respectively; P < 0.05), a better FFM maintenance after 3 and 5 wk (B = 1.5 and 1.9 kg, respectively; P < 0.05), a reduced REE (B = -16.7% of predicted; P = 0.01) after 3 wk, and a trend for a greater MUAC (B = 9.1; P = 0.06) and lower interleukin-6 production (B = -27.9; P = 0.08) after 5 wk. After 4 wk, the I group had a higher energy and protein intake than the C group (B = 2456 kJ/24 h, P = 0.03 and B = 25.0 g, P = 0.01, respectively). In conclusion, a protein- and energy-dense oral nutritional supplement containing (n-3) fatty acids beneficially affects nutritional status during multimodality treatment in patients with NSCLC. |
| | |
Authors:
|
Barbara S van der Meij; Jacqueline A E Langius; Egbert F Smit; Marieke D Spreeuwenberg; B Mary E von Blomberg; Annemieke C Heijboer; Marinus A Paul; Paul A M van Leeuwen |
Related Documents
:
|
1487965 - Occurrence of long and very long polyenoic fatty acids of the n-9 series in rat spermat... 16634535 - The relationship between tissue rbc n-3 fatty acids and pulse wave velocity. 7981185 - 13c-nmr spectroscopy of human atherosclerotic lesions. relation between fatty acid satu... 3821385 - Biological effects of fish oils in relation to chronic diseases. 12458955 - Super/subcritical fluid chromatography chiral separations with macrocyclic glycopeptide... 21489805 - Evaluation of superior bace1 cleavage sequences containing unnatural amino acids. |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't Date: 2010-08-25 |
Journal Detail:
|
Title: The Journal of nutrition Volume: 140 ISSN: 1541-6100 ISO Abbreviation: J. Nutr. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-21 Completed Date: 2010-10-19 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0404243 Medline TA: J Nutr Country: United States |
Other Details:
|
Languages: eng Pagination: 1774-80 Citation Subset: IM |
Affiliation:
|
Department of Nutrition and Dietetics, Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Biological Markers / blood Carcinoma, Non-Small-Cell Lung / therapy* Combined Modality Therapy Dietary Proteins / administration & dosage Dietary Supplements Double-Blind Method Eicosapentaenoic Acid / blood Energy Intake Energy Metabolism Fatty Acids, Omega-3 / administration & dosage* Female Humans Inflammation / blood Lung Neoplasms / therapy* Male Middle Aged Neoplasm Staging Nutritional Status / drug effects* Patient Compliance Phospholipids / blood Placebos |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Dietary Proteins; 0/Fatty Acids, Omega-3; 0/Phospholipids; 0/Placebos; 1553-41-9/Eicosapentaenoic Acid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Postprandial Lipid-Related Metabolites Are Altered in Dogs Fed Dietary Diacylglycerol and Low Glycem...
Next Document: A One-Year Intervention Has Modest Effects on Energy and Macronutrient Intakes of Overweight and Obe...